Dr. King Discusses Lymph Node Resection in Breast Cancer

Tari King, MD, FACS
Published: Wednesday, Dec 13, 2017



Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses lymph node resection in breast cancer.

One of the most feared side effects of breast cancer is lymphedema, says King. Recent data have shown that less surgery spares the morbidity of removing the lymph nodes, without compromising the patients' long-term outcomes.

Data such as these represent the de-escalation of surgical intervention in the treatment of patients with breast cancer, says King.
 


Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses lymph node resection in breast cancer.

One of the most feared side effects of breast cancer is lymphedema, says King. Recent data have shown that less surgery spares the morbidity of removing the lymph nodes, without compromising the patients' long-term outcomes.

Data such as these represent the de-escalation of surgical intervention in the treatment of patients with breast cancer, says King.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x